公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1999 | 3-hydroxy-3-methylglutaric aciduria presenting with Reye like syndrome: Report of one case | Lee C.; Tsai F.-J.; Wu J.-Y.; Peng C.-T.; Tsai C.-H.; WUH-LIANG HWU ; Wang T.-R.; Millington D.S. | Acta Paediatrica Taiwanica | 3 | 0 | |
2019 | Baicalein cardioprotection via oxidant scavenging and akt-nitric oxide signaling: Identification of early reperfusion phase as the critical therapeutic window | WEI-TIEN CHANG ; Li C.-Q.; Hsu C.-W.; Lee C.; Huang H.-H.; Yuan C.-S.; WEN-JONE CHEN ; Vanden Hoek T.L.; Shao Z.-H.; Li J. | American Journal of Chinese Medicine | 7 | 6 | |
2017 | Baicalein Preventive Treatment Confers Optimal Cardioprotection by PTEN/Akt/NO Activation | Li J.; WEI-TIEN CHANG ; Li C.-Q.; Lee C.; Huang H.-H.; Hsu C.-W.; WEN-JONE CHEN ; Zhu X.; Wang C.-Z.; Vanden Hoek T.L.; Shao Z.-H. | American Journal of Chinese Medicine | 16 | 15 | |
2002 | Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - A preliminary report | Wu H.; RUOH-FANG YEN ; Shen Y.; Kao C.; Lin C.; Lee C. | Journal of Cancer Research and Clinical Oncology | 84 | 61 | |
2019 | Cost-effectiveness analysis of human papillomavirus vaccination in adolescent girls in Taiwan | Tang C.-H.; WEN-FANG CHENG ; Jiang J.-H.; You S.L.; Huang L.-W.; Hsieh J.-Y.; Mukherjee P.; Van Kriekinge G.; Lee C. | Asian Pacific Journal of Cancer Prevention | 10 | 0 | |
2020 | Deep learning for Etiology of Chronic Kidney Disease in Taiwan | Chiu S.-M.; FENG-JUNG YANG ; Chen Y.-C.; Lee C. | 2nd IEEE Eurasia Conference on IOT, Communication and Engineering 2020, ECICE 2020 | 0 | 0 | |
2021 | Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan | Yin O.; Iwata H.; CHIA-CHI LIN ; Tamura K.; Watanabe J.; Wada R.; Kastrissios H.; AbuTarif M.; Garimella T.; Lee C.; Zhang L.; Shahidi J.; LaCreta F. | Clinical Pharmacology and Therapeutics | 22 | 15 | |
2010 | The impact of matching vaccine strains and post-sars public health efforts on reducing influenza-associated mortality among the elderly | Chan T.; CHUHSING KATE HSIAO ; Lee C.; Chiang P.; CHUAN-LIANG KAO ; Liu C.; King C. | PLoS ONE | 7 | 8 | |
2021 | Innovation Promoter or Inhibitor? Non-Family CEO's Effect on Innovation in Family Businesses | Chung P; Lee C; HSUEH-LIANG WU ; Lee C. | IEEE Transactions on Engineering Management | |||
2017 | Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial | Nash P.; Kirkham B.; Okada M.; Rahman P.; Combe B.; Burmester G.-R.; Adams D.H.; Kerr L.; Lee C.; Shuler C.L.; Genovese M.; Ahmed K.; Alper J.; Barkham N.; Bennett R.E.; Garc?a F.J.B.; Alonso R.B.; Blumstein H.B.; Brooks M.S.; Burmester G.-R.; Cagnoli P.; Caldron P.H.; Cantagrel A.; Chen D.-Y.; Churchill M.A.; Jr, Codding C.E.; Combe B.; Deane P.M.G.; Del Giudice J.; Deodhar A.A.; Dhar R.K.; Dokoupilova E.; Egan R.M.; Everding A.; Gal?ndez E.; Genovese M.; Goddard D.H.; Gottlieb A.; Goupille P.; Griffin R.M.; Gupta R.C.; Hall S.; Hatti K.; Howell M.P.; Huang Y.-H.; Jajoo R.; Janssen N.M.; Kiltz U.; Kivitz A.J.; Klein S.J.; Korkosz M.P.; Kotha R.; Kremer J.M.; Lue C.; de la Fuente J.L.M.; Marzo-Ortega H.; Masmitja J.G.; Mease P.J.; Meroni P.L.; Mueller E.C.; Nandagudi A.C.; Nash P.; Fern?ndez-Nebro A.; Neuwelt C.M.; Orbai A.M.; Oza M.R.; Parks D.L.; Pattanaik D.; Rell-Bakalarska M.E.; Rosmarin D.; Roussou E.; Rychlewska-Hanczewksa A.I.; Sikes D.H.; Stack M.T.; Sunkureddi P.; Tahir H.; Tha?i D.; TSEN-FANG TSAI ; Turkiewicz A.M.; Unger L.; Cabello R.V.; Wagner U.; Wei C.-C.; Wells A.F.; Youssef P.; Zielinska A. | The Lancet | 326 | 294 | |
2019 | Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial | Dimopoulos M.A.; Gay F.; Schjesvold F.; Beksac M.; Hajek R.; Weisel K.C.; Goldschmidt H.; Maisnar V.; Moreau P.; Min C.K.; Pluta A.; Chng W.-J.; Kaiser M.; Zweegman S.; Mateos M.-V.; Spencer A.; Iida S.; Morgan G.; Suryanarayan K.; Teng Z.; Skacel T.; Palumbo A.; Dash A.B.; Gupta N.; Labotka R.; Rajkumar S.V.; Bar D.; Basso A.; Fantl D.; He S.; Horvath N.; Lee C.; Rowlings P.; Taylor K.; Cochrane T.; Kwok F.; Ramanathan S.; Agis H.; Zojer N.; Kentos A.; Offner F.; Van Droogenbroeck J.; Wu K.L.; Maiolino A.; Martinez G.; Zanella K.; Capra M.; Araújo S.; Gregora E.; Pour L.; Scudla V.; Spicka I.; Abildgaard N.; Andersen N.; Jensen B.A.; Helleberg C.; Plesner T.; Salomo M.; Svirskaite A.; Delarue R.; Blau I.; Schieferdecker A.; Teleanu V.; Munder M.; Röllig C.; Salwender H.-J.; Fuhrmann S.; Weisel K.; Duerig J.; Zeis M.; Klein S.; Reimer P.; Schmidt C.; Scheid C.; Mayer K.; Hoffmann M.; Sosada M.; Dimopoulos A.; Delimpasi S.; Kyrtsonis M.-C.; Anagnostopoulos A.; Nagy Z.; Illés Á; Egyed M.; Borbényi Z.; Mikala G.; Dally N.; Horowitz N.; Gutwein O.; Nemets A.; Vaxman I.; Shvetz O.; Trestman S.; Ruchlemer R.; Nagler A.; Tadmor T.; Rouvio O.; Preis M.; Cavo M.; De Rosa L.; Musto P.; Cafro A.; Tosi P.; Offidani M.; Corso A.; Rossi G.; Liberati A.M.; Bosi A.; Suzuki K.; Nakaseko C.; Ishikawa T.; Matsumoto M.; Nagai H.; Sunami K.; Chou T.; Akashi K.; Takezako N.; Hagiwara S.; Eom H.S.; Jo D.-Y.; Kim J.S.; Lee J.H.; Yoon S.S.; Yoon D.H.; Kim K.; Levin M.-D.; Vellenga E.; Minnema M.; Waage A.; Haukås E.; Grosicki S.; Pluta A.; Robak T.; Marques H.; Bergantim R.; Campilho F.; Chng W.J.; Goh Y.T.; McDonald A.; Rapoport B.; Álvarez Rivas M.A.; De Arriba de La Fuente F.; González Montes Y.; Martin Sanchez J.; Mateos M.V.; Oriol Rocafiguera A.; Rosinol L.; San Miguel J.; Pérez de Oteyza J.; Encinas C.; Alegre-Amor A.; López-Guía A.; Axelsson P.; Carlson K.; Stromberg O.; Hansson M.; Hveding Blimark C.; Mueller R.; Chen C.-C.; Liu T.-C.; SHANG-YI HUANG ; Wang P.-N.; Na Nakorn T.; Prayongratana K.; Unal A.; Goker H.; Sonmez M.; Korenkova S.; Chaidos A.; Oakervee H.; Sati H.; Benjamin R.; Wechalekar A.; Garg M.; Ramasamy K.; Cook G.; Chantry A.; Jenner M.; Buadi F.; Berryman R.; Janakiram M.; TOURMALINE-MM3 study group | The Lancet | 181 | 167 | |
2009 | Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses | CHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN | Gastroenterology | 182 | 157 | |
2021 | Pharmacokinetics, safety, and efficacy of trastuzumab deruxtecan with concomitant ritonavir or itraconazole in patients with HER2-expressing advanced solid tumors | Takahashi S.; Karayama M.; Takahashi M.; Watanabe J.; Minami H.; Yamamoto N.; Kinoshita I.; CHIA-CHI LIN ; Im Y.-H.; Achiwa I.; Kamiyama E.; Okuda Y.; Lee C.; Bang Y.-J. | Clinical Cancer Research | 17 | 11 | |
2020 | Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning | Kang J.S.; Lee C.; Song W.; Choo W.; Lee S.; Lee S.; Han Y.; Bassi C.; Salvia R.; Marchegiani G.; Wolfgang C.L.; He J.; Blair A.B.; Kluger M.D.; Su G.H.; Kim S.C.; Song K.-B.; Yamamoto M.; Higuchi R.; Hatori T.; CHING-YAO YANG ; Yamaue H.; Hirono S.; Satoi S.; Fujii T.; Hirano S.; Lou W.; Hashimoto Y.; Shimizu Y.; Del Chiaro M.; Valente R.; Lohr M.; Choi D.W.; Choi S.H.; Heo J.S.; Motoi F.; Matsumoto I.; Lee W.J.; Kang C.M.; Shyr Y.-M.; Wang S.-E.; Han H.-S.; Yoon Y.-S.; Besselink M.G.; van Huijgevoort N.C.M.; Sho M.; Nagano H.; Kim S.G.; Honda G.; Yang Y.; Yu H.C.; Do Yang J.; Chung J.C.; Nagakawa Y.; Seo H.I.; Choi Y.J.; Byun Y.; Kim H.; Kwon W.; Park T.; Jang J.-Y. | Scientific Reports | 11 | 10 | |
2018 | Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2 | Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI ; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P. | Rheumatology (United Kingdom) | 35 | 33 |